sive renal failure, as Ang II not only contributes to glorenal failure. merular capillary hypertension, but also has a direct inBackground. Inhibition of the renin-angiotensin system by fluence on some functions of the mesangial cells and the both angiotensin II type 1 receptor antagonists (AT 1 As) and glomerular filtration barrier [2, 3]. In fact, inhibition of angiotensin I-converting enzyme inhibitors (ACEIs) shows rethe RAS by Ang II type 1 receptor antagonists (AT 1 As) noprotective effects in rats with chronic renal failure when treatment is started in the early phase of renal injury. In this or Ang I-converting enzyme inhibitors (ACEIs) has been study, we examined the renal protective effects of candesartan shown to have renoprotective effects in animal models cilexetil (TCV-116), an AT 1 A, and enalapril, an ACEI, in the with renal diseases and in patients with chronic renal progressive phase of renal injury in 5/6 nephrectomized rats. failure or diabetic nephropathy [4][5][6][7][8][9][10][11].
develop proteinuria and renal damage, early stage treatp.o., N ϭ 7), and enalapril-treated (10 mg/kg, p.o., N ϭ 7) 5/6 NX rats, as well as sham-operated normal twoment with the ACEI lisinopril completely protected against glomerulosclerosis, whereas the compound did kidney rats (N ϭ 5). At the onset of the both experiments, NX rats were divided into three groups with not prevent further development of glomerulosclerosis when it was administered in the progressive phase of equivalence of the values of urinary albumin excretion, urinary protein excretion, creatinine clearance (C Cr ), and glomerulosclerosis, despite fine control of both the systemic blood pressure and glomerular capillary presblood pressure to ensure equal severity of lesions in the remnant kidney. A one-way analysis of variance was sure [18] .
The 5/6 nephrectomized (5/6 NX) rat has commonly used to confirm the equal initial values of the previously mentioned four parameters in the both experiments. At been used as a model to investigate the effects of drugs on pathophysiological events in the progression of glothe onset of intervention in the short-term experiment, urinary total protein was 86.6 Ϯ 9.8, 89.4 Ϯ 11.1, and merulosclerosis. These rats also show renal functional 88.6 Ϯ 9.4 mg/day (P ϭ 0.981). Urinary albumin was and structural changes similar to those observed in pa-38.3 Ϯ 8.3, 39.0 Ϯ 9.1, and 38.4 Ϯ 8.2 mg/day (P ϭ 0.998). tients with end-stage kidney disease. This evidence C Cr was 0.25 Ϯ 0.02, 0.24 Ϯ 0.02, and 0.26 Ϯ 0.03 ml/ prompted us to compare the renal protective effects of min/100 g body wt (P ϭ 0.803). Blood pressure was long-term treatment with candesartan cilexetil (TCV-145.4 Ϯ 4.5, 143.6 Ϯ 3.5, and 144.2 Ϯ 6.0 mm Hg (P ϭ 116) [19] [20] [21] , an AT 1 A, and enalapril, an ACEI, in the 0.964) in the vehicle-treated, candesartan cilexetilprogressive phase of renal injury in 5/6 NX rats. To treated, and enalapril-treated groups, respectively. At evaluate the effect of post-treatment, these drugs were the onset of the intervention in the long-term experiadministered to the rats 15 weeks after the nephrectomy, ment, urinary total protein was 89.3 Ϯ 9.7, 85.9 Ϯ 11.6, that is, after they had already developed renal damage. and 89.8 Ϯ 15.5 mg/day (P ϭ 0.971). Urinary albumin was 39.0 Ϯ 8.1, 39.3 Ϯ 7.1, and 39.0 Ϯ 9.5 mg/day (P ϭ METHODS 0.999). C Cr was 0.23 Ϯ 0.01, 0.24 Ϯ 0.02, and 0.23 Ϯ 0.01 Experimental design ml/min/100 g body wt (P ϭ 0.998). Blood pressure was 149.9 Ϯ 2.7, 145.0 Ϯ 4.1, and 143.0 Ϯ 4.4 mm Hg (P ϭ Male five-week-old Sprague-Dawley rats, purchased from Japan Clea Laboratory (Tokyo, Japan), were sub-0.444) in vehicle-treated, candesartan cilexetil-treated, and enalapril-treated group, respectively. The doses of jected to a 5/6 renal NX, consisting of the surgical excision of approximately 2/3 of the renal cortex of the right candesartan cilexetil and enalapril (1 and 10 mg/kg, respectively) used in the experiments were chosen because kidney. One week later, the left kidney was removed. As shown in Figure 1 , drugs were administered once a they have been shown to provide equivalent hypotensive effects in spontaneously hypertensive rats [22] . At the day in the morning beginning 15 weeks after the nephrectomy, and the effects of drugs on the 4-week administraend of both experiments, rats were anesthetized with sodium pentobarbital (50 mg/kg, intraperitoneally), and tion (the short-term experiment) and the 16-week administration (the long-term experiment) were evaluated. a terminal blood sample was collected from the abdominal aorta. Then remnant kidneys of the 5/6 NX rats The short-term experiment consisted of the following four groups: vehicle-treated (N ϭ 5), candesartan cilexeand the right kidneys of the sham-operated rats were removed and fixed in 10% neutral-buffered formalin for til-treated (1 mg/kg, p.o., N ϭ 5), and enalapril-treated (10 mg/kg, p.o., N ϭ 5) 5/6 NX rats, as well as shamroutine histological studies or were frozen for immunohistochemical studies. All animal experiments were peroperated normal two-kidney rats (N ϭ 3). The long-term experiment consisted of following four groups: vehicleformed according to the guidelines of the Takeda Experimental Animal Care and Use Committee. treated (N ϭ 7), candesartan cilexetil-treated (1 mg/kg,
Measurement of blood pressure
were processed by the indirect immunoperoxidase technique. The number of glomeruli showing positive stainSystolic blood pressure was measured five hours after ing was expressed as a percentage of the total number the morning dose. Rats were maintained in individual of glomeruli present in a specimen. A negative control chambers warmed at 37ЊC, and systolic blood pressure value was obtained by replacing the primary antibody was measured using a tail-cuff (PS-8000; Riken Kaihatsu, with phosphate-buffered saline. Tokyo, Japan).
Drugs

Measurements of serum and urine parameters
Candesartan cilexetil (TCV-116), (Ϯ)-1-(cyclohexyTwenty-four-hour urine samples were collected with loxycarbonyloxy) ethyl 2-ethoxy-1-[[2Ј-(1H-tetrazolthe aid of metabolic cages. Blood was collected from 5-yl) biphenyl-4-yl] methyl]-1H-benzimidazole-7-carconscious rats via a tail vein using ethylenediaminetetraboxylate, and enalapril maleate were synthesized by acetic acid (EDTA) as an anticoagulant, and the plasma Takeda Chemical Industries, Ltd. (Osaka, Japan). was stored below Ϫ20ЊC. Urinary total protein, urinary albumin, urinary and plasma creatinine, and blood urea Statistical analysis nitrogen (BUN) were measured by conventional methData are expressed as mean Ϯ se. Differences between ods, using commercially available kits (Wako Pure the vehicle-treated group and the sham-operated group Chemicals, Osaka, Japan). Plasma renin activity (PRA) in values of urinary albumin excretion, total protein exwas estimated as the activity of Ang I production from cretion, systolic blood pressure, C Cr , plasma creatinine, endogenous angiotensinogen using a radioimmunoassay BUN, hematocrit, body weight, and kidney wet weight kit (SRL, Tokyo, Japan). Urinary prostaglandin E 2 were analyzed by Student's t-test. Differences between (PGE 2 ) was extracted from 24-hour urine samples acthe vehicle-treated group and the drug-treated groups cording to the method of Powell [23] . In brief, the urine for all parameters were analyzed by Dunnett's test. Bewas acidified to pH 3 with 1 N HCl and was passed cause the variance homogeneity criterion of the parametthrough Sep-pak light C18 cartridges (Millipore, Bedric test was not fulfilled in all data, the logarithm scale ford, MA, USA), and PGE 2 was eluted with ethanol/ transformation was applied to homogenize variances water (15:85). The amount of the extracted PGE 2 was where necessary, and the transformed data were used in measured using an enzyme immunoassay kit (Amerthe analysis. A P Ͻ 0.05 was considered to indicate a sham, Tokyo, Japan). In the long-term experiment, hesignificant difference. matocrit values were measured at the end of the 16-week administration period.
RESULTS
Histological studies
Proteinuria The kidneys were fixed in 10% neutral-buffered for- Figure 2 shows urinary total protein excretion (Fig. malin and were embedded in paraffin. Sections of 4 m 2A) and urinary albumin excretion (Fig. 2B ) in both the in thickness were stained with hematoxylin and eosin short-and long-term experiments. Urinary total protein (H&E), periodic acid-methenamine silver (PAM), and and urinary albumin excretion in the vehicle-treated rats Azan for the evaluation of glomerulosclerosis and tubuincreased with time, and the severity of the proteinuria lointerstitial lesions. For each rat, all glomerular crossbegan to increase sharply eight weeks after the first dose sections present in a specimen were evaluated, and the in the long-term experiment. Candesartan cilexetil and percentage of glomeruli exhibiting focal or global gloenalapril significantly prevented the progression of promerulosclerosis was determined. Glomerulosclerosis was teinuria in both experiments, and the effects of the two evidenced by segmental increases in the glomerular macompounds were comparable. trix, segmental collapse of capillary lumina, and/or adheBlood pressure sion to Bowman's capsule. Tubulointerstitial lesions were defined as mononuclear cell infiltration and interstiThe 5/6 nephrectomy resulted in the development of tial fibrosis. Lesions were assessed using the following systemic hypertension (Fig. 3 ). In the short-term experiscale: 0 ϭ normal, 1 ϭ small focal lesion, 2 ϭ multifocal ment, candesartan cilexetil tended to show a hypotensive lesion, 3 ϭ diffuse lesion, and 4 ϭ extensive lesion involveffect, and enalapril significantly decreased the systolic ing the entire cortex. To examine the expression of transblood pressure (124.3 Ϯ 2.2, 149.4 Ϯ 4.0, 140.4 Ϯ 4.7, forming growth factor-␤ 1 (TGF-␤ 1 ) in glomeruli, an imand 129.0 Ϯ 4.8 mm Hg for sham operated, vehicle, munohistochemical study was performed. Sections of candesartan cilexetil, and enalapril, respectively). In the fresh frozen tissue (12 m thick) were incubated with long-term experiment, both candesartan cilexetil and ena mouse monoclonal antibody against human TGF-␤ 1 alapril showed significant and comparable antihypertensive effects at the end of the 16-week administration (Antigenix America Inc., New York, NY, USA) and period (137.0 Ϯ 2.3, 151.9 Ϯ 2.6, 127.7 Ϯ 5.9, and 121.6 Ϯ of glomeruli with sclerotic lesions markedly increased, and interstitial fibrosis and mononuclear cell infiltration 5.1 mm Hg for sham operated, vehicle, candesartan cilexetil and enalapril, respectively).
were also observed. Both candesartan cilexetil and enalapril inhibited the progression of glomerulosclerosis and Histological findings tended to prevent the interstitial fibrosis and mononuclear cell infiltration. Table 1 shows the histological findings in the shortterm experiment. In the vehicle-treated rats, the number As shown in Figure 10 , urinary PGE 2 excretion in the (Fig. 4) and severe interstitial fibrosis (Fig. 5) were obenalapril-treated 5/6 NX rats was markedly increased at served in the vehicle-treated rats. ED1-positive inflamthe end of the 16-week administration period. matory cells (macrophages) were also observed in both Renal physiological parameters the glomeruli and interstitial areas (data not shown).
Creatinine clearance, plasma creatinine, BUN, kidney Figure 6 shows the quantitative analysis of these histologweight, and body weight at the end of the short-term ical findings. Candesartan cilexetil significantly inhibited experiment, and hematocrit in addition to these paramethe progression of the glomerulosclerosis (1.0 Ϯ 0.4, ters at the end of the long-term experiment were shown 25.9 Ϯ 4.4, 9.7 Ϯ 3.2, and 15.2 Ϯ 4.6% for sham operated, in Table 2 . In vehicle-treated groups, a significant invehicle, candesartan cilexetil, and enalapril-treated crease in plasma creatinine and BUN levels were obgroups, respectively; Fig. 6A ) and interstitial fibrosis served in the short-term experiment. Both drugs had no (0.0 Ϯ 0.0, 3.3 Ϯ 0.2, 1.9 Ϯ 0.3, and 2.6 Ϯ 0.2 score effect on these renal physiological parameters. At the for sham operated, vehicle, candesartan cilexetil, and end of the long-term experiment, a significant decrease enalapril-treated groups, respectively; Fig. 6B ), whereas in C Cr and an increase in plasma creatinine and BUN in enalapril did not show significant preventive effects.
the vehicle-treated group were observed. Neither drug Both drugs inhibited the mononuclear cell infiltration inhibited these adverse changes significantly. The hemacomparatively (0.0 Ϯ 0.0, 3.6 Ϯ 0.2, 2.1 Ϯ 0.3, and 2.1 Ϯ tocrit value in the vehicle-treated rats decreased as com-0.3 score for sham operated, vehicle-treated, candesartan pared with that in the sham-operated rats and was not cilexetil-treated, and enalapril-treated groups, respecaffected by either drug at the end of long-term experitively; Fig. 7) . Immunoreactive TGF-␤ 1 was expressed ment. The wet weight of the remnant kidney in the vehiin the glomeruli of the vehicle-treated rats, and the area cle-treated rats was higher than that of the normal right of expression was comparable to the location of sclerotic kidney in the sham-operated rats. Neither drug had any lesions (Fig. 8) . TGF-␤ 1 expression could not be detected effect on kidney weight in both of the experiments. Figin the interstitium. Figure 9 shows the quantitative analyure 11 shows PRA in the short-term experiments. PRA in the vehicle-treated rats showed a significant decrease sis of the glomerular TGF-␤ 1 expression in both shortas compared with the value in the sham-operated rats. and long-term experiments. The number of glomeruli PRA in the candesartan cilexetil-and enalapril-treated showing TGF-␤ 1 expression in the vehicle-treated rats rats was increased significantly as compared with that in increased with time. Candesartan cilexetil and enalapril the vehicle-treated rats. significantly inhibited the expression of TGF-␤ 1 in the glomeruli in the short-term experiment (0.0 Ϯ 0.0, 25.3 Ϯ 5.0, 7.9 Ϯ 4.2, and 2.2 Ϯ 0.6% for sham operated, vehicle-DISCUSSION treated, candesartan cilexetil-treated, and enalaprilThe aim of this study was to compare the renal protectreated groups, respectively). In the long-term experitive effects of candesartan cilexetil, an AT 1 A, and enalament, candesartan cilexetil markedly prevented the pril, an ACEI, on 4-week (short-term) and 16-week increase in the expression of TGF-␤ 1 , whereas the pre-(long-term) administration during the progressive phase ventive effect of enalapril decreased as compared with of renal injury in 5/6 NX rats. Drugs were administered that in the short-term experiment, and a significant effect to 5/6 NX rats starting 15 weeks after the nephrectomy. was not observed in the enalapril-treated rats (3.9 Ϯ 1.9,
In the short-term experiment, candesartan cilexetil and 37.4 Ϯ 6.4, 10.4 Ϯ 2.1, and 23.7 Ϯ 8.7% for sham operenalapril showed marked renal protective effects. Both ated, vehicle-treated, candesartan cilexetil-treated, and drugs suppressed proteinuria and glomerulosclerosis ( Fig. 2 and Table 1 ). These results coincided with the enalapril-treated groups, respectively). proteins in glomeruli [26] . Therefore, the accumulation of BK might induce the expression of TGF-␤ 1 in mesangial cells. It has also been reported that Ang II directly induces the expression of TGF-␤ 1 in cultured mesangial cells [2] . In this study, candesartan cilexetil markedly inhibited the enhanced expression of TGF-␤ 1 in the injured glomeruli. However, the suppressive effect of enalapril on TGF-␤ 1 expression decreased in the long-term experiment. These results suggest that the weakness of the inhibitory effect of enalapril on TGF-␤ 1 expression is caused by the accumulation of BK. In this study, we did not measure the content of BK in the kidney, but urinary PGE 2 excretion, which is induced by BK in the kidney [27] , increased significantly in only the enalapriltreated 5/6 NX rats in the long-term experiment (Fig.   Fig. 7 . Effects of candesartan cilexetil and enalapril on the interstitial 10), suggesting the accumulation of BK in the kidney. group was lower than that of the sham-operated group. It is conceivable that this reduction might be caused by the decrease in PGE 2 -producing cells of the remnant kidney because of both the initial renal ablation and the results of many previous studies designed to examine progression of injuries. Enalapril markedly increased the the renoprotective effects of earlier treatment with urinary PGE 2 excretion compared with vehicle; there-AT 1 As and ACEIs in 5/6 NX rats [4-9, 24]. In the longfore, the elevation of the PGE 2 excretion by enalapril term experiment, candesartan cilexetil significantly might be caused in part by the accumulation of BK. ameliorated the progression of glomerulosclerosis, the Because glomerular capillary hypertension induces gloglomerular expression of immunoreactive TGF-␤ 1 , and merular dysfunction, the amelioration of glomerular capinterstitial fibrosis, but enalapril did not, although both illary hypertension via a reduction of efferent arteriolar drugs showed the same hypotensive and antiproteinuretone is thought to prevent the development of glomerumic effects. The differences between candesartan cilexelar injury [4] [5] [6] [7] . It has been reported that the antagonism til and enalapril with regard to renal protective effects of Ang II with an AT 1 A causes less reduction in the may be explained as follows. glomerular efferent arteriolar tone than the inhibition First, the inhibition of ACE, namely, kininase II, by of ACE with an ACEI, because the accumulated BK an ACEI results in the accumulation of BK [15] . As BK causes efferent arteriole dilation [28, 29] . This suggests stimulates the proliferation of cultured rat mesangial that BK contributes to the renoprotective effects of cells [25] , and as the proliferation of mesangial cells plays ACEIs; however, in our study, enalapril did not show an important role in the progression of glomeruloscleroany advantage over candesartan cilexetil. sis, this effect of BK might counteract the renal protective Second, an AT 1 A can completely inhibit Ang II's efeffects of ACEIs. BK also activates AP-1 [25] , one of fects at the level of AT 1 receptors, whereas enalapril the major transcriptional factors of TGF-␤ 1 , which plays a pivotal role in the accumulation of extracellular matrix cannot inhibit the effect of Ang II produced by proteases other than ACE. In some organs, ACE-independent nals [13]. Because AT 2 receptors exist in the kidney of adult rats [34], activation of AT 2 receptors might have Ang I conversion is predominant in the generation of Ang II [30, 31] . Urata, Strobel, and Ganten reported that contributed to the beneficial renal protective effects of candesartan cilexetil, especially in the long-term experichymase, an ACEI-insensitive Ang II-forming protease, exists in the human renal cortex [32] . In the rat kidney, ment. According to a recent report, however, indirect AT 2 receptor activation stimulates the glomerular infilsome Ang II-forming pathways other than that involving ACE exist, and these may have contributed to the failure tration of monocytes/macrophages via RANTES expression, resulting in the progression of renal injury [35] . of the renoprotective effects of enalapril in the longterm experiment. For instance, cathepsin G contained However, in this study, AT 2 receptor activation did not seem to be an important factor for the infiltration of in infiltrating monocytes can generate Ang II from angiotensinogen directly [33] .
inflammatory cells because candesartan cilexetil and enalapril caused comparable inhibition of interstitial monoThird, AT 1 As are reported to activate AT 2 receptors via the elevation of plasma Ang II [16] . As AT 2 receptors nuclear cell infiltration. It has been established that the augmented production mediate antiproliferative and antifibrotic effects, AT 1 and AT 2 receptors might mediate counterbalancing sigof TGF-␤ 1 is important in the progression of interstitial [24, [36] [37] [38] [39] . In this AT 1 receptors, which are expressed in the same cells [42] , PRA seems to be an indicator of the extent of RAS study, the expression of TGF-␤ 1 in the interstitium was not observed. Wu et al reported that the expression of inhibition. After the four-week administration of both drugs in the short-term experiment, PRA increased to TGF-␤ 1 mRNA was detected in sclerotic glomeruli, areas of tubulointerstitial injury, and sites of mononuclear cell the same level, indicating that the extent of RAS inhibition by the two drugs was the same. infiltration by in situ hybridization for TGF-␤ 1 mRNA [24] . Muchaneta-Kubara, Sayed-Ahmed, and Nahas also Despite marked improvements of proteinuria and histopathological changes, candesartan cilexetil did not reported that immunoreactive TGF-␤ 1 expression in the interstitium was observed in the remnant kidney of 5/6
show a significant effect on renal function, demonstrated by C Cr , plasma creatinine, and BUN. It was reported that NX rats [40] . On the other hand, it has been reported that positive staining of TGF-␤ 1 was seen in the injured the progression rate of decrease in renal function was slower than the changes of proteinuria and histopatholglomeruli but not in the interstitium [41] . The reason for these differences remains unclear.
ogy [43] . In our study, the marked decrease in renal function was not observed during the intervention, even The inhibition of the RAS by AT 1 As and ACEIs elevates PRA [42] . As renin is produced in juxtaglomerular in the long-term experiment. As candesartan cilexetil significantly inhibited both proteinuria and histopathocells and secretion is regulated by the blockade of the experiments. A more prolonged follow-up study may be 55, 1992 necessary to clarify this puzzle.
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In conclusion, the renal protective effects of candesar- 
